Applied Therapeutics (APLT) Leases (2023 - 2025)
Historic Leases for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $2.5 million.
- Applied Therapeutics' Leases rose 2572.59% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 2572.59%. This contributed to the annual value of $2.8 million for FY2024, which is 52460.85% up from last year.
- Latest data reveals that Applied Therapeutics reported Leases of $2.5 million as of Q3 2025, which was up 2572.59% from $2.6 million recorded in Q2 2025.
- Applied Therapeutics' Leases' 5-year high stood at $2.8 million during Q4 2024, with a 5-year trough of $206000.0 in Q2 2024.
- In the last 3 years, Applied Therapeutics' Leases had a median value of $743000.0 in 2023 and averaged $1.4 million.
- Its Leases has fluctuated over the past 5 years, first crashed by 6719.75% in 2024, then surged by 115194.17% in 2025.
- Quarter analysis of 3 years shows Applied Therapeutics' Leases stood at $447000.0 in 2023, then soared by 524.61% to $2.8 million in 2024, then dropped by 11.6% to $2.5 million in 2025.
- Its last three reported values are $2.5 million in Q3 2025, $2.6 million for Q2 2025, and $2.7 million during Q1 2025.